Tag: Hepatitis
FDA Approves Mavyret for Children, Adolescents With Hep C
Drug approved for treatment of all six genotypes of hepatitis C virus in children ages 12 to 17
High Response Seen for All Hep C Tx Models in Injection Drug Users
Directly observed therapy tied to greater adherence than self-administered individual treatment
Heart, Lungs From Hep C-Infected Donor Can Be Transplanted Safely
Transplant into patients without HCV infection feasible, with excellent function at six months
HBV, HCV Control Aids Kidney Transplant Outcomes
Patients with viral suppression have outcomes similar to those of noninfected patients
Direct-Acting Antivirals Cut Mortality in Chronic Hepatitis C
Mortality, hepatocellular carcinoma risk reduced after adjustment for potential confounders
Hepatitis C Infection Rates Up After OxyContin Reformulation
222 percent increase in HCV infection rates seen after reformulation in states with above-median misuse
Public Health Interventions Could Cut Global Burden of Hepatitis C
Package of prevention, screening, treatments could avert 15.1 million new infections versus 2015
Direct-Acting Antivirals Not Tied to Liver Cancer Recurrence
Among patients with previous complete response to HCC tx, DAA not linked to overall or early recurrence
CDC: Proportion of Increased-Risk Deceased Organ Donors on Rise
Increased-risk donors significantly more likely to have positive HBV, HCV screening results
Many New Cancer Patients Unaware of Their Hepatitis Status
Large proportion of participants with newly diagnosed cancer learned of infection through study
